Your browser will redirect to your requested content shortly. This is a summary of current recommendations for GlaxoSmithKline plc (GSK.L) and Beximco Pharmaceuticals Limited (BXP.L), as reported by MarketBeat.com. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. This table compares GlaxoSmithKline plc (GSK.L) and Vectura Group's revenue, earnings per share and valuation. View our full suite of financial calendars and market data tables, all for free. This is a summary of recent recommendations and price targets for Eco Animal Health Group and GlaxoSmithKline plc (GSK.L), as provided by MarketBeat.com. GlaxoSmithKline plc (GSK.L) is trading at a lower price-to-earnings ratio than Dechra Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. Learn more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laxoSmithKline plc (GSK.L) pays an annual dividend of GBX 76 per share and has a dividend yield of 5.4%. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. This process is automatic. Export data to Excel for your own analysis. Learn about financial terms, types of investments, trading strategies and more. We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 This table compares GlaxoSmithKline plc (GSK.L) and AstraZeneca's net margins, return on equity and return on assets.

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Companies in the industry of "pharmaceutical preparations" are considered alternatives and competitors to GlaxoSmithKline, including Merck & Co., Inc. (MRK), Pfizer (PFE), Novartis (NVS), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), and AbbVie (ABBV). Dechra Pharmaceuticals pays out 103.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. See what's happening in the market right now with MarketBeat's real-time news feed. This table compares GlaxoSmithKline plc (GSK.L) and Dechra Pharmaceuticals' top-line revenue, earnings per share (EPS) and valuation. Given GlaxoSmithKline plc (GSK.L)'s higher probable upside, research analysts clearly believe GlaxoSmithKline plc (GSK.L) is more favorable than Vectura Group. We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, valuation, risk and profitability. Should you be buying GSK stock or one of its competitors? Eco Animal Health Group pays an annual dividend of GBX 15 per share and has a dividend yield of 7.2%.

Companies in the industry of "drug manufacturers - major" are considered alternatives and competitors to GlaxoSmithKline plc (GSK.L), including AstraZeneca (AZN), Dechra Pharmaceuticals (DPH), Hutchison China MediTech (HCM), Vectura Group (VEC), Beximco Pharmaceuticals Limited (BXP.L) (BXP), and Eco Animal Health Group (EAH). Given GlaxoSmithKline plc (GSK.L)'s higher probable upside, equities analysts clearly believe GlaxoSmithKline plc (GSK.L) is more favorable than Dechra Pharmaceuticals. All rights reserved. Your browser will redirect to your requested content shortly. In 2008, the pharmaceutical segment contributed 83.7% to GSK's tu… GlaxoSmithKline plc (GSK.L) (LON:GSK) and Dechra Pharmaceuticals (LON:DPH) are both medical companies, but which is the superior stock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his table compares GlaxoSmithKline plc (GSK.L) and Beximco Pharmaceuticals Limited (BXP.L)'s net margins, return on equity and return on assets. GlaxoSmithKline plc (GSK.L) pays an annual dividend of GBX 76 per share and has a dividend yield of 5.4%. Dechra Pharmaceuticals has a consensus target price of GBX 3,077.50, indicating a potential downside of 10.95%. AstraZeneca pays an annual dividend of GBX 216 per share and has a dividend yield of 2.6%. Merck generates 104% of GSK's revenue. © American Consumer News, LLC dba MarketBeat® 2010-2020.